Gastric cancer Trials in Shanghai, China
Conditions / Gastric cancer / Shanghai, China
Gastric cancer has been the subject of sustained clinical investigation across multiple research sites.
135 total trials for this combination
Showing top 10 of 135 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03619681 | Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer | COMPLETED | PHASE1 |
| NCT07066657 | A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study | RECRUITING | — |
| NCT07431281 | Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 | RECRUITING | PHASE3 |
| NCT05253053 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | COMPLETED | PHASE1/PHASE2 |
| NCT05860374 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | UNKNOWN | EARLY_PHASE1 |
| NCT05111626 | Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04511871 | A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT05489211 | Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) | RECRUITING | PHASE2 |
| NCT04644068 | Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |